TipHub

₹594

▼ -7.82 -1.30%

As of 13 Nov 2026 · delayed

NSE Listed · Pharmaceuticals

Concord Biotech Limited (CONCORDBIO)

Volume: 1,54,642Avg Vol 1W: 2,53,812Avg Vol 1M: 1,95,91952W Range:₹493.5₹1,615
NSE BSE www.concordbiotech.com AI Report
Key Ratios
Checked just now
Market Cap₹12,428 Cr
Current Price₹594
Previous Close₹601.82
High / Low (52w)₹1,615 / ₹493.5
Volume1,54,642
Avg Vol (1W)2,53,812
Avg Vol (1M)1,95,919
Stock P/E43.64
Book Value₹99.21
Dividend Yield63%
ROE13.61%
ROA12.01%
Revenue (TTM)—
Revenue Growth18.01%
Profit Margin24.13%
Total Debt₹0 Cr
Shares Outstanding21 Cr
Face Value₹1
EPS (TTM)₹13.61
P/B5.99
Debt / Equity0
50 DMA₹1,279.45
200 DMA₹1,240.87
Day change-1.30%
Price Chart
₹594▼ 60.38% · 1Y
₹1709₹5941.1Cr
2025-11-14
2026-11-13

20-day avg volume: 2.1L shares

Pros
  • Pays a dividend yield of 63.0%.
  • Company is almost debt-free.
  • Revenue grew 20% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Revenue₹244 Cr₹430 Cr₹204 Cr₹247 Cr₹278 Cr₹326 Cr₹257 Cr₹309 Cr
EBITDA₹99 Cr₹185 Cr₹57 Cr₹83 Cr₹90 Cr₹114 Cr₹77 Cr₹96 Cr
Net Profit₹76 Cr₹140 Cr₹44 Cr₹64 Cr₹64 Cr₹89 Cr₹59 Cr₹71 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026Sept 2026
Revenue₹1,245 Cr₹204 Cr₹247 Cr₹278 Cr₹326 Cr₹1,107 Cr₹261 Cr₹312 Cr
EBITDA₹496 Cr₹57 Cr₹86 Cr₹94 Cr₹118 Cr₹345 Cr₹82 Cr₹102 Cr
Net Profit₹372 Cr₹43 Cr₹63 Cr₹68 Cr₹90 Cr₹261 Cr₹61 Cr₹76 Cr
EPS35.52————24.78——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹941 Cr₹1,183 Cr₹1,313 Cr₹1,514 Cr₹1,701 Cr₹2,034 Cr₹2,235 Cr
Total Liabilities₹170 Cr₹183 Cr₹210 Cr₹224 Cr₹174 Cr₹222 Cr₹220 Cr
Equity₹770 Cr₹999 Cr₹1,103 Cr₹1,290 Cr₹1,527 Cr₹1,813 Cr₹2,015 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr₹367 Cr
Investing₹-114 Cr₹-112 Cr₹-158 Cr₹-155 Cr₹-160 Cr₹-143 Cr
Financing₹-43 Cr₹-100 Cr₹-85 Cr₹-99 Cr₹-99 Cr₹-113 Cr
Free Cash Flow₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr₹367 Cr
Shareholding
Promoter 44.09% Institutions 18.35% Public 37.57%
Efficiency & Working Capital
ROCE18%
Interest Coverage421.3
Dividend Payout—
Debtor Days159 d
Inventory Days113 d
Payable Days35 d
Cash Conversion Cycle237 d
Working Capital Days272 d
Shareholding Details

As of 2026-11-30

Promoter44.1%
FII7.3%
DII11%
Institutions18.3%
Public37.6%
Promoter Pledge0%
No. of Shareholders91,337
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026Nov 2026
Promoters44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%
FIIs6.5%7.1%8.1%8.3%9.4%9.1%8%7.6%7.8%7.5%7.3%7.3%
DIIs8.5%10.4%9.9%9.7%9.2%8.9%9.6%9.6%9.2%9.4%11%11%
Public41%38.4%37.9%37.9%37.4%37.9%38.3%38.8%38.9%39%37.7%37.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders83,29680,73784,29882,00481,21982,04582,65081,81582,24983,32588,36591,337
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sudhir Kumar VaidShareholding of Promoter and Promoter Group28.8%6.03 Cr
Manju VaidShareholding of Promoter and Promoter Group9.6%2.00 Cr
Aryavir Jhunjhunwala Discretionary TrustPublic Shareholding8%1.68 Cr
Aryaman Jhunjhunwala Discretionary TrustPublic Shareholding8%1.68 Cr
Nishtha Jhunjhunwaladiscretionary TrustPublic Shareholding8%1.68 Cr
Sudman Consultants LlpShareholding of Promoter and Promoter Group4.5%95,04,000
Dsp Healthcare FundPublic Shareholding3.2%67,12,182
Government Pension Fund GlobalPublic Shareholding3%62,03,304
Tata Aia Life Insurance Co Ltd-growth Enabler Fund-ulif 015 17/10/07 Tge 110Public Shareholding2.7%56,77,088
Amal ParikhPublic Shareholding1.9%40,46,438
Axis Max Life Insurance Limited A/c Usipf - Smart Innovation Pension FundPublic Shareholding1.3%27,81,526
Ravindra Raichand DharamshiPublic Shareholding1.2%25,12,864
Chanakya Corporate Services Pvt LtdPublic Shareholding1.1%23,27,666
Sbi Nifty Smallcap 250 Index FundPublic Shareholding1.1%22,15,178
Ankur Sudhir VaidShareholding of Promoter and Promoter Group0.6%11,73,040
Vaid Megha AnkurShareholding of Promoter and Promoter Group0.5%10,94,016
Sonal KumraShareholding of Promoter and Promoter Group0.1%1,47,840
Gaurav KumraShareholding of Promoter and Promoter Group0%11,000
Concord Lifegen LimitedShareholding of Promoter and Promoter Group0%0
Clean Max Everglades Private LimitedShareholding of Promoter and Promoter Group0%0
Concord Biotech Japan KkShareholding of Promoter and Promoter Group0%0
Celliimune Biotech Private LimitedShareholding of Promoter and Promoter Group0%0
Stellon Biotech Inc.Shareholding of Promoter and Promoter Group0%0
Aarav VaidShareholding of Promoter and Promoter Group0%0
Myra VaidShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
SUDHIR JAIRAM VAIDChairman / Executive Director / M D / Promoter2026
ANKUR VAIDED / Joint MD / CEO / Promoter2026
Ravi KapoorNon-Exec & Non-Independent Dir2026
Rajiv AgarwalNon-Exec & Non-Independent Dir2026
BHARTI KHANNAIndependent Non Exe. Director2026
Amitabh ThakoreIndependent Non Exe. Director2026
Arvind AgarwalIndependent Non Exe. Director2026
Jayaram EaswaranIndependent Non Exe. Director2026
Mandayam Chakravarthy SriramanIndependent Non Exe. Director2026
Paritosh TrivediCompany Sec. & Compli. Officer2026
EKTA GUPTAIndependent Non Exe. Director2026
Segments — Geography
RegionRevenueShare
Within India₹662 Cr55.1%
America₹138 Cr11.5%
Others₹400 Cr33.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1111010
Corporate Actions
TypeDateValueRemark
forthcoming2026-11-04Bonus—
bonus2026-11-041:11:1 Bonus Issue Of Equity Shares
forthcoming2026-07-31Board Meetings—
forthcoming2026-07-24Dividend (7.55/- per share)Final
dividend2026-07-24₹7.55 (755%)Final
dividend2025-09-03₹10.7 (1070%)Final
forthcoming—Book ClosureAGM & 755% Final Dividend
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202631033495132
202614000014
2026150449588
Insider / Designated-Person Trades

11 recent disclosure(s)

Prakash Lalchand SajnaniDisposal · 5,000
Chandrashekhar Mukundrao ChawanDisposal · 1,000
Devang BhattDisposal · 3,000
Kanishka KapoorDisposal · 10,000
Ravi KapoorDisposal · 10,000
Rajendra ModiDisposal · 4,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market28/05/2024 · 35,48,211
Company Information
Incorporated1984
ChairmanSUDHIR JAIRAM VAID
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.concordbiotech.com ↗

📍 1482-86 Trasad Road, Dholka, Ahmedabad, Gujarat, 382225

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Committed Cargo Care Ltd.Competent Automobiles Company Ltd.Compuage Infocom Ltd.Compucom Software Ltd.Commercial Syn Bags Ltd.Container Corporation Of India Ltd.Confidence Petroleum India Ltd.Connplex Cinemas LimitedConsolidated Finvest & Holdings Ltd.Continental Seeds and Chemicals Ltd.Control Print LimitedCool Caps Industries Ltd.All “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search